3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Ovarian Neoplasms
15
Fallopian Tube Neoplasms
13
Lung Neoplasms
11
Melanoma
8
Glioblastoma
7
Colorectal Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Carcinoma, Hepatocellular
7
Urinary Bladder Neoplasms
6
Triple Negative Breast Neoplasms
6
Carcinoma, Renal Cell
6
Uterine Cervical Neoplasms
4
Pancreatic Neoplasms
4
Breast Neoplasms
4
Brain Neoplasms
4
Prostatic Neoplasms
3
Neoplasm Metastasis
3
Nasopharyngeal Carcinoma
3
Uveal Melanoma
2
Thyroid Neoplasms
2
Small Cell Lung Carcinoma
2
Sarcoma
2
Rectal Neoplasms
2
Oligodendroglioma
2
Multiple Myeloma
2
Medulloblastoma
2
Lymphoma
2
Liposarcoma
2
Hematologic Neoplasms
2
Gliosarcoma
2
Interventions
Ifosfamide
15
Methotrexate
12
Doxorubicin
12
Filgrastim
10
Cisplatin
10
Cyclophosphamide
9
Etoposide
8
Gemcitabine
7
cabozantinib
6
apatinib
6
Magnetic Resonance Spectroscopy
6
Leucovorin
6
X-Rays
5
Specimen Handling
5
Sirolimus
5
Phantoms, Imaging
5
Nivolumab
5
Neoadjuvant Therapy
5
camrelizumab
4
Vincristine
4
Topotecan
4
Radiotherapy
4
Nuclear Medicine Department, Hospital
4
Drug Therapy
4
Docetaxel
4
Biopsy
4
regorafenib
3
palbociclib
3
olaparib
3
mifamurtide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Osteosarcoma
×
Immunoglobulin G
×
Clear all
NCT04668300
2026-04-15
DOSa
M.D. Anderson Cancer Center
Phase 2
Active not recruiting
75 enrolled